Mergers & AcquisitionsBy The Online Investor Staff, updated Sat., Nov. 17, 1:17 AM
|This Slide: #2 of 100|
Slide #2. INVICTUS MD STRATEGIES CORP. — 0989561 B.C. Ltd.
INVICTUS MD STRATEGIES CORP. (CVE:GENE.CA)
0989561 B.C. Ltd.
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has successfully exercised its option to acquire 100% (the "Option") of the outstanding shares of 0989561 B.C. Ltd. ("Canandia") from its current shareholders (see press releases dated: May 16, 2018, July 18, 2018 and October 15, 2018, for more details).
Invictus MD Strategies is engaged in the investment, acquisition, and development of synergistic businesses in an effort to increase and sustain growth, value and profits in the medical cannabis industry. Acreage Pharms is a licensed producer of medical cannabis in Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). Future Harvest produces and sells plant fertilizers, nutrients and other supplies for hydroponics. Poda develops technology to vaporize cannabis. AB Laboratories is a licensed producer and seller of medical cannabis in Canada, and AB Ventures is in the application phase for a license to produce medical cannabis under ACMPR.
Open the GENE.CA Page at The Online Investor »